Intellectual Property India Publishes Patent Application for Triterpenoid Antifungals For Use In The Treatment Of Mucormycosis

MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202617091227 A) filed by Scynexis, Inc. on July 27, 2026, for Triterpenoid Antifungals For Use In The Treatment Of Mucormycosis.

Inventor includes Angulo Gonzalez, David, A..

The application for the patent was published on October 23, 2026, under issue no. 43/2026.

Abstract: Enfumafungin derivative triterpenoid antifungal compounds are used to treat mucormycosis. The enfumafungin derivative triterpenoids (or pharmaceutically acceptable salts or hydrates thereof) are inhibitors of (1,3)-ß-D-glucan synthesis and are useful alone or in combination with a second antifungal agent in the treatment of mucormycosis, including pulmonary mucormycosis.

Discla...